4/A: Hims & Hers Health CEO Exercises Stock Options Under 10b5-1 Plan

CEO Andrew Dudum exercised stock options of Hims & Hers Health, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• Andrew Dudum, CEO of Hims & Hers Health, Inc., executed transactions involving stock options on January 16, 2025.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.
• Dudum exercised options to acquire 17,001 and 16,667 shares of Class A Common Stock at an exercise price of $2.43.
• Following these transactions, Dudum directly owns 170,014 and 1,548,068 derivative securities.
• The options were initially granted for shares of Hims, Inc. and converted following the company's business combination in 2021.
• Alexandra Cotter Wilkins, Attorney-in-Fact, signed the form on January 23, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction under a pre-existing plan. The exercise of options can be seen as a positive signal, but it's not necessarily indicative of significant outperformance.

Positives

• The CEO's exercise of stock options demonstrates confidence in the company's future.
• The use of a 10b5-1 trading plan ensures transparency and avoids accusations of insider trading.

Industry Context

Stock option exercises by executives are a common occurrence, particularly in publicly traded companies. The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.

Stakeholder Impact

• The exercise of stock options could have a minor dilutive effect on existing shareholders.

Key Dates